The power to target muscle to
stop or reverse disease progression
On World FSHD Day and every day, Dyne is dedicated to making a difference by advancing potentially life-transforming therapies for individuals and families living with FSHD.

Scientific Publications & Presentations

May 14, 2021
Splice Correction and Reduction of Toxic DMPK RNA In Vitro and In Vivo Utilizing Novel Antibody Targeted Antisense Oligonucleotides Presented at American Society of Gene & Cell Therapy Annual Meeting (ASGCT), May 14, 2021